UBE2E3 regulates cellular senescence and osteogenic differentiation of BMSCs during aging
Background Osteoporosis has gradually become a public health problem in the world. However, the exact molecular mechanism of osteoporosis still remains unclear. Senescence and osteogenic differentiation inhibition of bone marrow mesenchymal stem cells (BMSCs ) are supposed to play an important part...
Guardado en:
Autores principales: | Yalin Liu, Guangping Cai, Peng Chen, Tiejian Jiang, Zhuying Xia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8005adf9ae834890bb5a191d5798d839 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ultra-Small Lysozyme-Protected Gold Nanoclusters as Nanomedicines Inducing Osteogenic Differentiation
por: Li K, et al.
Publicado: (2020) -
Polymorphism of gene UBE2E2 and the risk of developing diabetes type 2
por: Elena Vladimirovna Kazakova, et al.
Publicado: (2015) -
Chikungunya Virus Infection Impairs the Function of Osteogenic Cells
por: Enakshi Roy, et al.
Publicado: (2020) -
MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10
por: You M, et al.
Publicado: (2021) -
Angptl2 is a Marker of Cellular Senescence: The Physiological and Pathophysiological Impact of Angptl2-Related Senescence
por: Nathalie Thorin-Trescases, et al.
Publicado: (2021)